专题:Viral Infectious Diseases and Gene Expression in Insects

This cluster of papers focuses on the production of recombinant proteins, particularly in mammalian and insect cells. It covers topics such as transient transfection, baculovirus expression systems, glycosylation, virus-like particles, and monoclonal antibody production. The research also delves into cell culture processes and biopharmaceutical production.
最新文献
Evaluating Dextrose-Derived Interference in Low-Concentration Monoclonal Antibody Quantification for Clinical In-Use Studies

article Full Text OpenAlex

Oncolytic viruses: advanced strategies in cancer therapy

article Full Text OpenAlex

Designing an ISO 23247-compliant Hybrid Digital Twin Architecture for industry

article Full Text OpenAlex

mGem: AAV, from almost a virus to an awesome vector—or is it?

article Full Text OpenAlex

Toward precision in nanoscale IR spectroscopy: Optimizing biological sample preparation for molecular and morphological integrity

article Full Text OpenAlex

Purification and immunogenicity of Nipah virus-like particles from insect cells

article Full Text OpenAlex

Fitness Landscape for Antibodies 2: Benchmarking Reveals That Protein AI Models Cannot Yet Consistently Predict Developability Properties

article Full Text OpenAlex

Viral clearance in biopharmaceutical manufacturing: Current strategies, challenges, and future directions

article Full Text OpenAlex

Development of Cell Culture Media for Cultivated Meat Production

book-chapter Full Text OpenAlex

On the impact of mechanistic model quality and data availability in hybrid model development

article Full Text OpenAlex

近5年高被引文献
CB-Dock2: improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting

article Full Text OpenAlex 1641 FWCI200.4303

Long-term outcomes following CAR T cell therapy: what we know so far

review Full Text OpenAlex 1233 FWCI271.3433

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

article Full Text OpenAlex 945 FWCI84.5912

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy

review Full Text OpenAlex 614 FWCI59.3129

Therapy with oncolytic viruses: progress and challenges

review Full Text OpenAlex 514 FWCI152.2066

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

review Full Text OpenAlex 485 FWCI42.3485

Biopharmaceutical benchmarks 2022

article Full Text OpenAlex 478 FWCI35.7882

CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn

review Full Text OpenAlex 457 FWCI100.6525

CAR T therapy beyond cancer: the evolution of a living drug

review Full Text OpenAlex 457 FWCI100.6045

Oncolytic virotherapy: basic principles, recent advances and future directions

review Full Text OpenAlex 376 FWCI111.4226